Taken together, these data show that XR5944 is a potent cytotoxic agent that can induce at least additive activity in combination with 5-FU or CPT-11 in vitro against both p53 mutant and wild-type colon carcinoma cell lines. Here, TP53 is linked to colon carcinoma.